Eslicarbazepine
Also known as: Aptiom.
Wholesale (NADAC) cost for every strength and dosage form — the price pharmacies pay, published weekly by CMS. Not your out-of-pocket price.
Wholesale (NADAC) prices — every strength & form
| Strength | Form | NADAC / unit | Class |
|---|---|---|---|
| 200 MG | Tablet | $2.06 / unit | Generic |
| 400 MG | Tablet | $2.93 / unit | Generic |
| 600 MG | Tablet | $2.95 / unit | Generic |
| 800 MG | Tablet | $2.65 / unit | Generic |
Wholesale (NADAC) — the price pharmacies pay, not your out-of-pocket price.
NADAC week of 2026-07-01 · updated weekly · source CMS
Medicaid & Medicare spending · 2024
In 2024, Medicaid paid $125,387,342 gross for Eslicarbazepine across 65,830 prescriptions (measured, national).
Medicare Part D EST spent an estimated ~$144,071,383 gross (retail pharmacy only; excludes Part B).
Gross program spending, before rebates — not what patients pay out of pocket. Brand net cost is materially lower after confidential rebates; generics are close to net.
Source: Medicaid SDUD 2024 · Medicare Part D 2024 · CMS